Skip to main content

Table 2 main characteristic of included studies

From: Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: a systematic review and Meta-analysis

references Country Year Sample Size Study Design Quality Assessment Criteria Positive cases OR Age > 30 Low CI Age > 30 High CI Age > 30 OR Female Low CI Female High CI Female OR High school Low CI High school High CI High school OR Unprotected sex Low CI Unprotected sex High CI Unprotected sex OR Duration of injecting drug use Low CI Duration of injecting drug use High CI Duration of injecting drug use OR Past treatment attempt Low CI Past treatment attempt High CI Past treatment attempt OR Previous testing Low CI Previous testing High CI Previous testing
[32] USA 2012 533 Cross-section Good 469        1.9 1.4 2.5             
[33] India 2015–2016 1241 Cross-section Very Good 298        3.5 1.2 10.4 0.5 0.3 0.9 2.1 1 4.2       
[34] Greece 2013–2015 2747 Cross-section Very Good 2294 2.6 1.6 4.3           3 2 4.5 3.6 2.6 4.8    
[35] Australia 2016–2018 565 Cohort Very Good 367     1.92 1.11 3.3              2.15 0.97 4.8
[36] Australia 2007 888 Cross-section Good 826        0.36 0.18 0.81        2.78 1.48 5.2    
[37] Thailand 2011 427 Cross-section Very Good 141        2.2 1.35 3.64 0.62 0.32 0.97     3.47 1.85 6.95    
[38] Ukraine 2014–2015 1613 Cross-section Satisfactory 348     1.61 1.08 2.41        0.98 0.96 1 2.24 1.32 3.81    
[39] Australia 215 1173 Cross-section Good 633                 2.15 1.149 3.87 2 1.31 3.06
[40] Germany 2020 2059 Cross-section Satisfactory 1503 2.2 1.2 4.2                   
[41] India 2013–2017 11,993 Cross-section Good                  1.72 1.22 2.43    
[42] USA 2012–2013 129 Cross-section Good 107 4.2 1.7 7.5                   
[43] Spain 2011 240 Cross-section Very Good 179                      
[42] USA 2012–2013 129 Cross-section Very Good 107                      
[44] USA 2015 14,253 Cross-section Good 157                      
[45] Canada 2012–2013 663 Cross-section Satisfactory 564                      
[46] USA 2003–2004 217 Cross-section Good 100                      
[47] UK 2012–2015 211 Cross-section Very good 135                      
[41] India 2013–2017 11,993 Cross-section Good 469                      
  1. OR Odds Ratio
  2. CI Confidence Interval